Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

Published:2021-10-20 Issue:1 Volume:36 Page:11-18
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Rose Ronald,Gartland Margaret,Li Zhufang,Zhou Nannan,Cockett Mark,Beloor Jagadish,Lataillade Max,Ackerman Peter,Krystal Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. Fostemsavir in adults with multidrug-resistant HIV-1 Iifection;Kozal;N Engl J Med,2020

2. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study;Lataillade;Lancet HIV,2020

3. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action;Langley;Proteins,2015

4. Release of gp120 restraints leads to an entry-competent intermediate state of the HIV-1 envelope glycoproteins;Herschhorn;MBio,2016

5. Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529;Pancera;Nat Chem Biol,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate;Antiviral Research;2024-09

2. Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumab;Antiviral Research;2024-08

3. Development of an extended action fostemsavir lipid nanoparticle;Communications Biology;2024-07-30

4. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

5. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3